Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19

Arshad, Samia; Kilgore, Paul E.; Chaudhry, Zohra; Jacobsen, Gordon; Wang, Dee Dee; Huitsing, Kylie; Brar, Indira; Alangaden, George; Ramesh, Mayur; McKinnon, John E.; O’Neill, William W.; Zervos, Marcus; Nauriyal, Varidhi; Hamed, Asif Abdul; Nadeem, Owais; Swiderek, Jennifer; Godfrey, Amanda; Jennings, Jeffrey; Gardner-Gray, Jayna; Ackerman, Adam; Lezotte, Jonathan; Ruhala, Joseph; Fadel, Raef; Vahia, Amit; Gudipati, Smitha; Parraga, Tommy; Shallal, Anita; Maki, Gina; Tariq, Zain; Suleyman, Geehan; Yared, Nicholas; Herc, Erica; Williams, Johnathan; Lanfranco, Odaliz Abreu; Bhargava, Pallavi; Reyes, Katherine

doi:10.1016/j.ijid.2020.06.099

articleInternational Journal of Infectious DiseasesJul 2, 2020GOLD OA

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19

SASamia Arshad PEPaul E. Kilgore ZCZohra Chaudhry GJGordon Jacobsen DDDee Dee Wang

Henry Ford Hospital · Eugene Applebaum College of Pharmacy and Health Sciences · +1 more institution

PubMed

Indexed incrossrefdoajpubmed

Abstract

Significance

The United States is in an acceleration phase of the COVID-19 pandemic. Currently there is no known effective therapy or vaccine for treatment of SARS-CoV-2, highlighting urgency around identifying effective therapies.

Objective

The purpose of this study was to evaluate the role of hydroxychloroquine therapy alone and in combination with azithromycin in hospitalized patients positive for COVID-19.

Citation impact

566

total citations

FWCI: 13.68
Percentile: 100%
References: 42

Citations per year

Authors

36

Topics & keywords

Topics

Keywords

Hydroxychloroquine
Azithromycin
Medicine
Coronavirus disease 2019 (COVID-19)
Internal medicine
Retrospective cohort study
Pediatrics
Disease

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.

Funding

HF
Henry Ford Health System